Antithrombin III in patients admitted to intensive care units: a multicenter observational study

INTRODUCTION: The administration of antithrombin III (ATIII) is useful in patients with congenital deficiency, but evidence for the other therapeutic indications of this drug is still uncertain. In Italy, the use of ATIII is very common in intensive care units (ICUs). For this reason we undertook an...

Descripción completa

Detalles Bibliográficos
Autores principales: Messori, Andrea, Vacca, Franca, Vaiani, Monica, Trippoli, Sabrina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC130146/
https://www.ncbi.nlm.nih.gov/pubmed/12398786
http://dx.doi.org/10.1186/cc1540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC130146/
https://www.ncbi.nlm.nih.gov/pubmed/12398786
http://dx.doi.org/10.1186/cc1540

Ejemplares similares